Drawing for EYEDO

USPTO serial 97920440

EYEDO

Reviewed by CopyMark Law Group

Reg. 7412004Status 700Registered
Filing date
Status date
Registration date
Jun 11, 2024
Examiner
ADEJUNMOBI, AKIN T
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EYEDO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pina Campagna

PINA CAMPAGNA CARTER, DELUCA AND FARRELL LLP576 BROAD HOLLOW RD.MELVILLE, NY 11747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Recorded and downloadable computer programs for accessing, browsing and searching online clinical, pathology, and molecular biology databases; Electronic database in the field of clinical, pathology and molecular biology recorded on computer media; Recorded and downloadable software for managing, analysing, processing and sharing clinical data and medical images; Recorded and downloadable software for image consultation, file transmission, searching within clinical, pathology, and molecular biology databases; Recorded and downloadable software for the visualisation, distribution and communication of medical images and clinical data; Recorded and downloadable software for management of pathology images; Recorded and downloadable software for data management and database searching for patient identification, patient stratification, and selection of investigator centres for preclinical, translational and clinical research; Recorded and downloadable software for conducting medical and scientific research; Recorded and downloadable software for clinical trial research including oncology clinical trials; Recorded and downloadable software for clinical trial research using artificial intelligence and data science technology; Recorded and downloadable software for interpretation of pathology data and images for analysis, diagnosis and prognosis of multimodal medical imaging for personalised medicineACTIVE—
042Medical research services related to the treatment of patients; Conception, development and maintenance of software for managing, analysing, processing and sharing clinical data and medical images; Conception, development and maintenance of software for image consultation, file transmission, searching within clinical, pathology and molecular biology databases; Conception, development and maintenance of integrated software for the visualisation, distribution and communication of medical images and clinical data; Conception, development and maintenance of pathology image management software; Conception of clinical, pathology and molecular biology databases; data analysis and electronic storage of scientific, clinical, pathology and molecular biology data; Conception, development and maintenance of data management and database search software for patient identification, or patient stratification, and selection of investigator centres for preclinical, translational and clinical research; Conception, development and maintenance of software for medical and scientific research; Conception, development and maintenance of software for clinical trial research including oncology clinical trials; Conception, development and maintenance of software for clinical trial research using artificial intelligence and data science technology; Conception, development and maintenance of medical software for interpretation of pathology data and images for analysis, diagnosis and prognosis of multimodal medical imaging for personalised medicine; Computerised data analysis services for patient identification, patient stratification, and selection of investigator centres for preclinical, translational and clinical research; Medical and scientific research in the field of medical imaging; Conception and development of medical technologies in the field of cancer, inflammatory and rare diseases therapeutics development, diagnostics and theragnostics; Conception and development of medical diagnostic devices in the field of cancer, inflammatory and rare diseases; Provision of medical and scientific research information in the field of clinical trials; Medical research; Biological, clinical and medical research; Scientific research for medical purposes in the field of cancer, inflammatory and rare diseases therapeutics development, diagnostics and theragnostics; Computer graphics services; computer services, namely, electronic digitizing of images; Computer data analysis services in the field of medical imagingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 11, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 6, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 16, 2024FIXDELECTRONIC RECORD REVIEW COMPLETE—
Feb 9, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Feb 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Feb 1, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 1, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 1, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 30, 2024DOCKASSIGNED TO EXAMINER—
Jun 2, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance